Drugs / Vanicream
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05436535 Background | Nov 2022 → Apr 2025 | atopic eczema | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vanicream | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05436535 ↗ |
| Route | Topical | “apply Vanicream at least twice daily to the specified target skin area” NCT05436535 ↗ |